Bio-Techne Corporation (TECH) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Bio-Techne Corporation (TECH) Bundle
Whether you’re an investor or analyst, this (TECH) DCF Calculator is your go-to resource for accurate valuation. Loaded with real data from Bio-Techne Corporation, you can adjust forecasts and view the effects in real-time.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 738.7 | 931.0 | 1,105.6 | 1,136.7 | 1,159.1 | 1,302.7 | 1,464.1 | 1,645.6 | 1,849.5 | 2,078.7 |
Revenue Growth, % | 0 | 26.04 | 18.75 | 2.81 | 1.97 | 12.39 | 12.39 | 12.39 | 12.39 | 12.39 |
EBITDA | 373.9 | 258.5 | 420.1 | 460.6 | 310.4 | 478.5 | 537.8 | 604.5 | 679.4 | 763.6 |
EBITDA, % | 50.62 | 27.76 | 38 | 40.52 | 26.78 | 36.73 | 36.73 | 36.73 | 36.73 | 36.73 |
Depreciation | 82.7 | 87.7 | 101.1 | 107.2 | 111.7 | 127.2 | 143.0 | 160.7 | 180.7 | 203.0 |
Depreciation, % | 11.2 | 9.42 | 9.14 | 9.43 | 9.64 | 9.77 | 9.77 | 9.77 | 9.77 | 9.77 |
EBIT | 291.2 | 170.7 | 319.0 | 353.3 | 198.7 | 351.3 | 394.8 | 443.8 | 498.7 | 560.6 |
EBIT, % | 39.42 | 18.34 | 28.86 | 31.08 | 17.14 | 26.97 | 26.97 | 26.97 | 26.97 | 26.97 |
Total Cash | 270.9 | 231.6 | 247.0 | 204.3 | 152.9 | 299.7 | 336.9 | 378.6 | 425.6 | 478.3 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 122.5 | 145.4 | 194.5 | 218.5 | 241.4 | 234.1 | 263.1 | 295.7 | 332.3 | 373.5 |
Account Receivables, % | 16.59 | 15.62 | 17.6 | 19.22 | 20.83 | 17.97 | 17.97 | 17.97 | 17.97 | 17.97 |
Inventories | 103.2 | 116.7 | 141.1 | 171.6 | 179.7 | 182.0 | 204.6 | 230.0 | 258.5 | 290.5 |
Inventories, % | 13.96 | 12.54 | 12.76 | 15.1 | 15.51 | 13.97 | 13.97 | 13.97 | 13.97 | 13.97 |
Accounts Payable | 23.1 | 29.4 | 33.9 | 25.7 | 38.0 | 38.8 | 43.6 | 49.0 | 55.0 | 61.9 |
Accounts Payable, % | 3.13 | 3.16 | 3.06 | 2.26 | 3.28 | 2.98 | 2.98 | 2.98 | 2.98 | 2.98 |
Capital Expenditure | -51.7 | -44.3 | -44.9 | -38.2 | -62.9 | -64.1 | -72.1 | -81.0 | -91.0 | -102.3 |
Capital Expenditure, % | -7 | -4.76 | -4.06 | -3.36 | -5.42 | -4.92 | -4.92 | -4.92 | -4.92 | -4.92 |
Tax Rate, % | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 |
EBITAT | 241.5 | 161.8 | 288.0 | 297.6 | 179.8 | 311.1 | 349.6 | 392.9 | 441.6 | 496.3 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | 69.9 | 175.1 | 275.1 | 304.0 | 210.0 | 380.0 | 373.8 | 420.1 | 472.1 | 530.7 |
WACC, % | 10.25 | 10.27 | 10.26 | 10.25 | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 |
PV UFCF | ||||||||||
SUM PV UFCF | 1,610.7 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | 552 | |||||||||
Terminal Value | 8,821 | |||||||||
Present Terminal Value | 5,414 | |||||||||
Enterprise Value | 7,025 | |||||||||
Net Debt | 268 | |||||||||
Equity Value | 6,757 | |||||||||
Diluted Shares Outstanding, MM | 161 | |||||||||
Equity Value Per Share | 42.03 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real Bio-Techne Corporation (TECH) financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effects of your inputs on Bio-Techne Corporation’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Customizable Forecast Inputs: Adjust essential metrics such as revenue growth, EBITDA %, and capital investments.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other key metrics.
- High-Precision Accuracy: Leverages Bio-Techne’s actual financial data for realistic valuation results.
- Effortless Scenario Analysis: Easily evaluate various assumptions and analyze different outcomes.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- Download: Get the pre-built Excel file containing Bio-Techne Corporation’s (TECH) financial data.
- Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to fit your analysis.
- Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various projections and instantly compare the results.
- Make Decisions: Leverage the valuation findings to inform your investment approach.
Why Choose Bio-Techne Corporation (TECH)?
- Innovative Solutions: Access cutting-edge technologies and products tailored for life sciences.
- Commitment to Quality: High standards in research and development ensure reliable results.
- Extensive Product Range: A diverse portfolio meets various needs across multiple disciplines.
- Expert Support: Dedicated customer service and technical assistance available for all users.
- Recognized Leader: Trusted by researchers and professionals in the scientific community.
Who Should Use This Product?
- Investors: Accurately estimate Bio-Techne Corporation’s (TECH) fair value before making investment decisions.
- CFOs: Leverage a professional-grade DCF model for financial reporting and analysis related to Bio-Techne Corporation (TECH).
- Consultants: Quickly adapt the template for valuation reports tailored to Bio-Techne Corporation (TECH) clients.
- Entrepreneurs: Gain insights into financial modeling practices utilized by leading biotech firms like Bio-Techne Corporation (TECH).
- Educators: Use it as a teaching tool to demonstrate valuation methodologies relevant to Bio-Techne Corporation (TECH).
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Bio-Techne Corporation (TECH) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Bio-Techne Corporation (TECH).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.